Gossamer Bio, Inc. (GOSS) Nonoperating Income (Expense) USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Gossamer Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2024.
  • Gossamer Bio, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $31 K.
  • Gossamer Bio, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $5.2 M.
  • Gossamer Bio, Inc. annual Nonoperating Income (Expense) for 2023 was $3.94 M.
  • Gossamer Bio, Inc. annual Nonoperating Income (Expense) for 2022 was -$10.8 M, a 39.7% increase from 2021.
  • Gossamer Bio, Inc. annual Nonoperating Income (Expense) for 2021 was -$17.9 M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $5.2 M $31 K +$1.25 M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $3.94 M $879 K +$2.29 M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $1.66 M $482 K +$3.82 M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$2.17 M $3.8 M +$6.4 M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$8.57 M -$1.22 M +$2.22 M +64.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$10.8 M -$1.41 M +$3.22 M +69.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$14 M -$3.34 M +$1.24 M +27.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$15.2 M -$2.59 M +$1.64 M +38.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$16.9 M -$3.44 M +$996 K +22.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$17.9 M -$4.62 M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 -$4.58 M -$340 K -8.01% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$4.24 M -$2.71 M -177% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$4.44 M -$5.33 M -597% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 -$3.79 M -$4.24 M -$5.73 M -386% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $1.94 M -$1.53 M -$3.38 M -183% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $5.32 M $893 K -$513 K -36.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $5.83 M $1.09 M +$76 K +7.5% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-24
Q3 2019 $5.76 M $1.49 M +$864 K +139% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $4.89 M $1.85 M +$1.55 M +517% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $3.34 M $1.41 M +$1.32 M +1480% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $2.02 M $1.01 M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-24
Q3 2018 $622 K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $300 K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $89 K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.